Intermittent parathyroid hormone 1-34 induces oxidation and deterioration of mineral and collagen quality in newly formed mandibular bone

被引:6
作者
Yoshioka, Yohsuke [1 ]
Yamachika, Eiki [2 ]
Nakanishi, Makoto [3 ]
Ninomiya, Tadashi [4 ]
Akashi, Sho [1 ]
Kondo, Sei [1 ]
Moritani, Norifumi [1 ]
Kobayashi, Yasuhiro [5 ]
Fujii, Tatsuo [3 ]
Iida, Seiji [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan
[2] Okayama Univ Hosp, Dept Oral & Maxillofacial Reconstruct Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan
[3] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Appl Chem, Kita Ku, 1-1-1 Tsushima Naka, Okayama, Japan
[4] Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo, Japan
[5] Matsumoto Dent Univ, Inst Oral Sci, Div Hard Tissue Res, 1780 Gobara Hirooka, Nagano, Japan
关键词
OSTEOPOROSIS; MECHANISMS; INCREASES; MELATONIN; STRENGTH; IMPLANTS; THERAPY;
D O I
10.1038/s41598-019-44389-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intermittent parathyroid hormone (PTH) administration is known to promote bone healing after surgical procedures. However, the mechanism and influence of PTH on the mineral and collagen quality of the jaw are not well understood. Most studies have focused on analyzing the bone density and microstructure of the mandible, and have insufficiently investigated its mineral and collagen quality. Oxidative stress activates osteoclasts, produces advanced glycation end products, and worsens mineral and collagen quality. We hypothesized that PTH induces oxidation and affects the mineral and collagen quality of newly formed mandibular bone. To test this, we examined the mineral and collagen quality of newly formed mandibular bone in rats administered PTH, and analyzed serum after intermittent PTH administration to examine the degree of oxidation. PTH administration reduced mineralization and worsened mineral and collagen quality in newly formed bone. In addition, total anti-oxidant capacity in serum was significantly decreased and the oxidative-INDEX was increased among PTH-treated compared to vehicle-treated rats, indicating serum oxidation. In conclusion, intermittent administration of PTH reduced mineral and collagen quality in newly formed mandibular bone. This effect may have been induced by oxidation.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface
    Y. F. Li
    X. D. Li
    C. Y. Bao
    Q. M. Chen
    H. Zhang
    J. Hu
    Osteoporosis International, 2013, 24 : 1063 - 1071
  • [42] Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration
    Kimura, S.
    Saito, M.
    Kida, Y.
    Seki, A.
    Isaka, Y.
    Marumo, K.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (03) : 1109 - 1119
  • [43] Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: A randomized double-masked prospective study using three dose levels
    Fujita, T
    Inoue, T
    Morii, H
    Morita, R
    Norimatsu, H
    Orimo, H
    Takahashi, HE
    Yamamoto, K
    Fukunaga, M
    OSTEOPOROSIS INTERNATIONAL, 1999, 9 (04) : 296 - 306
  • [44] Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: A comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893
    Stewart, AF
    Cain, RL
    Burr, DB
    Jacob, D
    Turner, CH
    Hock, JM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (08) : 1517 - 1525
  • [45] Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys
    Burr, DB
    Hirano, T
    Turner, CH
    Hotchkiss, C
    Brommage, R
    Hock, JM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) : 157 - 165
  • [46] Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    BONE, 2001, 28 (05) : 538 - 547
  • [47] The influence of parathyroid hormone 1-34 on the osteogenic characteristics of adipose- and bone-marrow-derived mesenchymal stem cells from juvenile and ovarectomized rats
    Osagie-Clouard, L.
    Sanghani-Kerai, A.
    Coathup, M.
    Meeson, R.
    Briggs, T.
    Blunn, G.
    BONE & JOINT RESEARCH, 2019, 8 (08): : 397 - 404
  • [48] Quantitative Study of Parathyroid Hormone (1-34) and Bone Morphogenetic Protein-2 on Spinal Fusion Outcomes in a Rabbit Model of Lumbar Dorsolateral Intertransverse Process Arthrodesis
    Lina, Ioan A.
    Puvanesarajah, Varun
    Liauw, Jason A.
    Lo, Sheng-fu L.
    Santiago-Dieppa, David R.
    Hwang, Lee
    Mao, Annie
    Bydon, Ali
    Wolinsky, Jean-Paul
    Sciubba, Daniel M.
    Gokaslan, Ziya
    Holmes, Christina
    Witham, Timothy F.
    SPINE, 2014, 39 (05) : 347 - 355
  • [49] Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
    M. Sridharan
    J. Cheung
    A. E. Moore
    M. L. Frost
    W. D. Fraser
    I. Fogelman
    G. Hampson
    Calcified Tissue International, 2010, 87 : 398 - 405
  • [50] Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
    Geeta Hampson
    Calcified Tissue International, 2011, 88